Related Experiment Video
Updated: Mar 9, 2026

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Allergy reduces the risk of meningioma: a meta-analysis
Peng-Fei Wang1, Wen-Jun Ji2, Xiao-Hui Zhang3
1Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University, China.
Abstract:
Meningiomas are the most common brain tumours; however, little is known regarding their aetiology. The data are inconsistent concerning atopic disease and the risk of developing meningioma. Thus, we conducted a meta-analysis to investigate the association between allergic conditions and the risk of developing meningioma. A systematic literature search was conducted using PubMed and Web of SCI from Jan 1979 to Feb 2016. Two investigators independently selected the relevant articles according to the inclusion criteria. Eight case-control studies and 2 cohort studies were included in the final analysis, comprising 5,679 meningioma cases and 55,621 control subjects. Compared with no history of allergy, the pooled odds ratio (OR) for allergic conditions was 0.81 (0.70-0.94) for meningioma in a random-effects meta-analysis. Inverse correlations of meningioma occurrence were also identified for asthma and eczema, in which the pooled ORs were 0.78 (0.70-0.86) and 0.78 (0.69-0.87), respectively. A reduced risk of meningioma occurrence was identified in hay fever; however, the association was weak (0.88, 95% CI = 0.78-0.99). The source of this heterogeneity could be the various confounding variables in individual studies. Overall, the current meta-analysis indicated that allergy reduced the risk of developing meningiomas. Large cohort studies are required to investigate this relationship.
Insights
Allergic conditions, including asthma and eczema, are associated with a reduced risk of developing meningiomas, the most common brain tumors. This meta-analysis suggests allergies may offer a protective effect against meningioma development.
Area of Science:
- Neuro-oncology
- Epidemiology
- Immunology
Background:
- Meningiomas are the most common primary brain tumors, but their etiology remains poorly understood.
- Existing data on the link between atopic (allergic) diseases and meningioma risk are inconsistent.
Purpose of the Study:
- To conduct a meta-analysis investigating the association between allergic conditions and the risk of developing meningioma.
- To clarify the relationship between specific allergic diseases and meningioma risk.
Main Methods:
- A systematic literature search was performed using PubMed and Web of Science databases (1979-2016).
- Included studies were evaluated by two independent investigators based on predefined criteria.
- Data from 8 case-control and 2 cohort studies, involving 5,679 meningioma cases and 55,621 controls, were pooled for analysis.
Main Results:
- A pooled odds ratio (OR) of 0.81 (95% CI: 0.70-0.94) indicated a reduced risk of meningioma in individuals with allergic conditions compared to those without.
- Inverse correlations were observed for asthma (OR: 0.78; 0.70-0.86) and eczema (OR: 0.78; 0.69-0.87).
- Hay fever showed a weaker, though significant, association with reduced meningioma risk (OR: 0.88; 0.78-0.99).
Conclusions:
- The findings suggest that allergic conditions are associated with a decreased risk of developing meningiomas.
- Potential confounding variables may contribute to heterogeneity across studies.
- Further large-scale cohort studies are warranted to confirm this protective association.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions
Allergic Reactions: Anaphylaxis
Psychoneuroimmunology: Diabetes and Cancer
Drug Toxicity: Allergic Reactions

